These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 27833440

  • 1. Levamisole therapy in children with frequently relapsing and steroid-dependent nephrotic syndrome: a single-center experience.
    Kuźma-Mroczkowska E, Skrzypczyk P, Pańczyk-Tomaszewska M.
    Cent Eur J Immunol; 2016; 41(3):243-247. PubMed ID: 27833440
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome - A retrospective comparative analysis.
    Sharma S, Kalra S, Shukla S, Sharma P.
    Nephrology (Carlton); 2022 Sep; 27(9):758-762. PubMed ID: 35619554
    [Abstract] [Full Text] [Related]

  • 3. Levamisole in Frequently-relapsing and Steroid-dependent Nephrotic Syndrome.
    Kiruba Samuel EM, Krishnamurthy S, Bhanudeep S, Muske S.
    Indian Pediatr; 2017 Oct 15; 54(10):831-834. PubMed ID: 28699616
    [Abstract] [Full Text] [Related]

  • 4. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
    Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
    BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of levamisole treatment in childhood nephrotic syndrome.
    Sümegi V, Haszon I, Iványi B, Bereczki C, Papp F, Túri S.
    Pediatr Nephrol; 2004 Dec 01; 19(12):1354-60. PubMed ID: 15517419
    [Abstract] [Full Text] [Related]

  • 6. Association between the time of initial relapse and subsequent relapses in patients with childhood-onset idiopathic nephrotic syndrome.
    Inoki Y, Nishi K, Osaka K, Kaneda T, Akiyama M, Sato M, Ogura M, Kamei K.
    Pediatr Nephrol; 2024 Aug 01; 39(8):2393-2401. PubMed ID: 38267591
    [Abstract] [Full Text] [Related]

  • 7. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
    Larkins N, Kim S, Craig J, Hodson E.
    Arch Dis Child; 2016 Apr 01; 101(4):404-8. PubMed ID: 26289063
    [Abstract] [Full Text] [Related]

  • 8. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
    Basu B, Babu BG, Mahapatra TK.
    Clin Exp Nephrol; 2017 Feb 01; 21(1):143-151. PubMed ID: 27108294
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
    Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L.
    Nephrology (Carlton); 2016 Jan 01; 21(1):21-7. PubMed ID: 26697959
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of Levamisole in children with Frequent Relapsing and Steroid Dependent Nephrotic Syndrome at Tertiary Care Center-Karachi.
    Moorani KN, Zubair AM, Veerwani NR, Hotchandani HJ.
    Pak J Med Sci; 2020 Jan 01; 36(6):1193-1198. PubMed ID: 32968379
    [Abstract] [Full Text] [Related]

  • 11. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
    Zhonghua Er Ke Za Zhi; 2014 Mar 01; 52(3):194-200. PubMed ID: 24824389
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome.
    Ekambaram S, Mahalingam V, Nageswaran P, Udani A, Geminiganesan S, Priyadarshini S.
    Indian Pediatr; 2014 May 01; 51(5):371-3. PubMed ID: 24953577
    [Abstract] [Full Text] [Related]

  • 13. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A, Isfahani ST, Rahimzadeh N, Fereshtehnejad SM, Hoseini R, Moghtaderi M, Mohseni P, Ataiee N.
    Iran J Kidney Dis; 2010 Oct 01; 4(4):292-6. PubMed ID: 20852369
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A.
    Kidney Int; 2019 Jan 01; 95(1):210-218. PubMed ID: 30497684
    [Abstract] [Full Text] [Related]

  • 15. Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study.
    Banerjee S, Sengupta J, Sinha R, Chatterjee S, Sarkar S, Akhtar S, Saha R, Pahari A.
    Pediatr Nephrol; 2024 Oct 01; 39(10):2969-2977. PubMed ID: 38822220
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate Mofetil in the Treatment of Steroid-Dependent or Frequently Relapsing Nephrotic Syndrome in Children: A Meta-Analysis.
    Xiang X, Qiu SY, Wang M.
    Front Pediatr; 2021 Oct 01; 9():671434. PubMed ID: 34211944
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A, Hari P, Moudgil A, Jordan SC.
    Am J Kidney Dis; 2003 Dec 01; 42(6):1114-20. PubMed ID: 14655181
    [Abstract] [Full Text] [Related]

  • 18. Levamisole in Children with Idiopathic Nephrotic Syndrome: Clinical Efficacy and Pathophysiological Aspects.
    Mühlig AK, Lee JY, Kemper MJ, Kronbichler A, Yang JW, Lee JM, Shin JI, Oh J.
    J Clin Med; 2019 Jun 16; 8(6):. PubMed ID: 31208104
    [Abstract] [Full Text] [Related]

  • 19. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
    Singh DN, Krishnamurthy S, Kamalanathan SK, Harichandrakumar KT, Sivamurukan P.
    Paediatr Int Child Health; 2018 Nov 16; 38(4):251-260. PubMed ID: 30092157
    [Abstract] [Full Text] [Related]

  • 20. Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial).
    Nagano C, Sako M, Kamei K, Ishikura K, Nakamura H, Nakanishi K, Omori T, Nozu K, Iijima K.
    BMC Nephrol; 2019 Aug 02; 20(1):293. PubMed ID: 31375087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.